These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease. Sáez-González E; Moret I; Alvarez-Sotomayor D; Díaz-Jaime FC; Cerrillo E; Iborra M; Nos P; Beltrán B Dig Dis Sci; 2017 Jun; 62(6):1417-1425. PubMed ID: 28432476 [TBL] [Abstract][Full Text] [Related]
6. Developments in the apheresis procedure for the treatment of inflammatory bowel disease. Pineda AA Inflamm Bowel Dis; 2006 Jan; 12 Suppl 1():S10-4. PubMed ID: 16378005 [TBL] [Abstract][Full Text] [Related]
7. Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease. Mitsuyama K; Yamasaki H; Kuwaki K; Takedatsu H; Sata M Curr Pharm Des; 2009; 15(18):2110-9. PubMed ID: 19519448 [TBL] [Abstract][Full Text] [Related]
8. Cytapheresis (CAP) with leukocyte removal filter/bead column as one therapeutic option for inflammatory bowel disease. Sawada K Transfus Apher Sci; 2017 Oct; 56(5):689-697. PubMed ID: 28986009 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects. Ramlow W; Emmrich J; Ahrenholz P; Sparmann G; Kashiwagi N; Franz M; Yokoyama T; Yoshikawa T J Clin Apher; 2005 Jul; 20(2):72-80. PubMed ID: 15892085 [TBL] [Abstract][Full Text] [Related]
13. Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Ohara M; Saniabadi AR; Kokuma S; Hirata I; Adachi M; Agishi T; Kasukawa R Artif Organs; 1997 Sep; 21(9):989-94. PubMed ID: 9288869 [TBL] [Abstract][Full Text] [Related]
14. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Kanai T; Hibi T; Watanabe M Expert Opin Biol Ther; 2006 May; 6(5):453-66. PubMed ID: 16610976 [TBL] [Abstract][Full Text] [Related]
15. Cytapheresis in inflammatory bowel diseases: current evidence and perspectives. Danese S; Angelucci E; Stefanelli T; Omodei P; Luigiano C; Finazzi S; Pagano N; Repici A; Vecchi M; Malesci A Digestion; 2008; 77(2):96-107. PubMed ID: 18382085 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis. Hasegawa M; Kawamura N; Murase M; Koide S; Kushimoto H; Murakami K; Tomita M; Hiki Y; Shikano M; Sugiyama S Ther Apher Dial; 2004 Jun; 8(3):212-6. PubMed ID: 15154873 [TBL] [Abstract][Full Text] [Related]
17. Selective leukocyte apheresis for the treatment of inflammatory bowel disease. Abreu MT; Plevy S; Sands BE; Weinstein R J Clin Gastroenterol; 2007; 41(10):874-88. PubMed ID: 18090155 [TBL] [Abstract][Full Text] [Related]
18. New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease. Kawamura A; Saitoh M; Yonekawa M; Horie T; Ohizumi H; Tamaki T; Kukita K; Meguro J Ther Apher; 1999 Nov; 3(4):334-7. PubMed ID: 10608731 [TBL] [Abstract][Full Text] [Related]
19. Leukocytapheresis therapy by extracorporeal circulation using a leukocyte removal filter. Suemitsu J; Yoshida M; Yamawaki N; Yamashita Y Ther Apher; 1998 Feb; 2(1):31-6. PubMed ID: 10227786 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte/monocyte apheresis as immunotherapic tool: cellular adsorption and immune modulation. Cuadrado E Autoimmun Rev; 2009 Feb; 8(4):292-6. PubMed ID: 18804557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]